Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Special Care in Dentistry : Official Publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry|February 24, 2001
The dental management of a patient with a cocaine-induced maxillofacial defect: a case reportN Tsoukalas, C D Johnson, R L Engelmeier, et al.
European Journal of Gynaecological Oncology|October 25, 2012
Metastatic bone involvement in vulvar cancer: report of a rare case and review of the literatureM Tolia, N Tsoukalas, K Platoni, et al.
Oncology Letters|December 19, 2013
Complete remission of a reccurrent mesenteric liposarcoma with rare histological features following the administration of trabectedinN Tsoukalas, M Tolia, G Lypas, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|April 21, 2012
Meta-analysis of the predictive value of KRAS mutations in treatment response using cetuximab in colorectal cancerN Tsoukalas, A A Tzovaras, M Tolia, et al.
Annals of the Royal College of Surgeons of England|April 17, 2018
Mucinous breast carcinoma with tall columnar cellsN Tsoukalas, M Kiakou, M Tolia, et al.
Experimental Oncology|October 12, 2023
SYNCHRONOUS DIAGNOSIS OF TESTICULAR AND THYROID CANCER IN A YOUNG MALEN Tsoukalas, M Kiakou, M Tolia, et al.
Annals of the Royal College of Surgeons of England|January 25, 2020
Desmoplastic small round-cell tumour of the peritoneal cavity: case report and literature reviewN Tsoukalas, M Kiakou, G Nakos, et al.
ESMO Open|November 13, 2021
Vaccine third dose and cancer patients: necessity or luxury?G Pappas, E Saloustros, A Boutis, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Real-world efficacy and toxicity data of paclitaxel and ramucirumab compared with other treatment regimens in patients with advanced gastric cancerE Fountzilas, J Souglakos, J Alafis, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Real-world safety and effectiveness data of trastuzumab deruxtecan and sacituzumab govitecan in breast cancer: a Hellenic Cooperative Oncology Group studyE Fountzilas, S Karageorgopoulou, G Karakatsoulis, et al.
Pageof 2